| Category: |
Antibody |
| Concentration: |
2ml sterile DI water, 5mg/ml if reconstituted with 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
ALDH1A2 |
| Host animal: |
Rabbit (Oryctolagus cuniculus) |
| Clonality: |
Polyclonal (rabbit origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, Mouse (Mus musculus), Rat , we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
WB |
| Recommended dilutions: |
5-1ug/ml, Western blot: 0 |
| Added buffer: |
025% sodium azide, 5% BSA and 0, Lyophilized from 1X Phosphate Buffered Saline (PBS) with 2 |
| Intented use: |
This ALDH1A2 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot #: |
O94788 |
| Purity: |
Antigen affinity |
| Description: |
Four transcript variants encoding distinct isoforms have been identified for this gene, Retinoic acid, The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde, The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, This protein belongs to the aldehyde dehydrogenase family of proteins, also known as ALDH1A2 or retinaldehyde dehydrogenase 2 (RALDH2), concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida, is a hormonal signaling molecule that functions in developing and adult tissues, is an enzyme that in humans is encoded by the ALDH1A2 gene, member A2, the active derivative of vitamin A (retinol), Aldehyde dehydrogenase 1 family |
| Immunogen: |
Amino acids M1-A110 from the human protein were used as the immunogen for the ALDH1A2 antibody |
| Storage: |
After reconstitution, Avoid repeated freezing and thawing, Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, aliquot and store at -20 deg, store at 4oC, the ALDH1A2 antibody may be kept for up to one month refrigerated at +4 degrees C, For long-term, Prior to reconstitution |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
ALDH1A2 |
| Short name: |
ALDH1A2 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
member A2 (Antibody to), aldehyde dehydrogenase 1 family |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ALDH1A2 and IDBG-13982 and ENSG00000128918 and 101928635, ALDH1A2 and IDBG-646601 and ENSBTAG00000010119 and 535075, Aldh1a2 and IDBG-182855 and ENSMUSG00000013584 and 19378, Cytoplasm, NAD or NADP as acceptor, NAD or NADP as acceptor and also this GO :0016918 : retinal binding, NAD or NADP as acceptor and molecular function this GO :0016918 and retinal binding and molecular function this GO :0021915 and neural tube development and biological process this GO :0021983 and pituitary gland development and biological process this GO :0030182 and neuron differentiation and biological process this GO :0030324 and lung development and biological process this GO :0030326 and embryonic limb morphogenesis and biological process this GO :0030900 and forebrain development and biological process this GO :0030902 and hindbrain development and biological process this GO :0031016 and pancreas development and biological process this GO :0031076 and embryonic camera-type eye development and biological process this GO :0032355 and response to estradiol and biological process this GO :0033189 and response to vitamin A and biological process this GO :0034097 and response to cytokine and biological process this GO :0035115 and embryonic forelimb morphogenesis and biological process this GO :0035799 and ureter maturation and biological process this GO :0042572 and retinol metabolic process and biological process this GO :0042573 and retinoic acid metabolic process and biological process this GO :0042574 and retinal metabolic process and biological process this GO :0042904 and 9-cis-retinoic acid biosynthetic process and biological process this GO :0043010 and camera-type eye development and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0048384 and retinoic acid receptor signaling pathway and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0048566 and embryonic digestive tract development and biological process this GO :0048738 and cardiac muscle tissue development and biological process this GO :0055114 and oxidation-reduction process and biological process this GO :0060324 and face development and biological process this GO :0071300 and cellular response to retinoic acid and biological process, RALDH(II) and RALDH2 and RALDH2-T, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, member A2, oxidoreductase activity, this GO :0001568 and blood vessel development and biological process this GO :0001758 and retinal dehydrogenase activity and molecular function this GO :0001822 and kidney development and biological process this GO :0001889 and liver development and biological process this GO :0001936 and regulation of endothelial cell proliferation and biological process this GO :0002138 and retinoic acid biosynthetic process and biological process this GO :0003007 and heart morphogenesis and biological process this GO :0004028 and 3-chloroallyl aldehyde dehydrogenase activity and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006776 and vitamin A metabolic process and biological process this GO :0007494 and midgut development and biological process this GO :0008152 and metabolic process and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0009855 and determination of bilateral symmetry and biological process this GO :0009952 and anterior/posterior pattern specification and biological process this GO :0009954 and proximal/distal pattern formation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0014032 and neural crest cell development and biological process this GO :0016331 and morphogenesis of embryonic epithelium and biological process this GO :0016491 and oxidoreductase activity and molecular function this GO :0016620 and oxidoreductase activity, this GO :0001758 : retinal dehydrogenase activity, this GO :0001758 : retinal dehydrogenase activity and also this GO :0004028 : 3-chloroallyl aldehyde dehydrogenase activity and also this GO :0016491 : oxidoreductase activity and also this GO :0016620 : oxidoreductase activity, this GO :0004028 : 3-chloroallyl aldehyde dehydrogenase activity, this GO :0016491 : oxidoreductase activity, this GO :0016620 : oxidoreductase activity, this GO :0016918 : retinal binding, 8854, aldehyde dehydrogenase 1 family |
| Identity: |
15472 |
| Gene: |
ALDH1A2 |
More about : ALDH1A2 |
| Long gene name: |
aldehyde dehydrogenase 1 family member A2 |
| Synonyms gene name: |
aldehyde dehydrogenase 1 family, member A2 |
| Synonyms: |
RALDH2 |
| Synonyms name: |
retinaldehyde dehydrogenase 2 |
| Locus: |
15q21, 3 |
| Discovery year: |
2001-03-30 |
| GenBank acession: |
AB015228 |
| Entrez gene record: |
8854 |
| Pubmed identfication: |
9819382 |
| Classification: |
Aldehyde dehydrogenases |
| Havana BLAST/BLAT: |
OTTHUMG00000132624 |